Open AccessEfficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis
Author(s) -
Caitriona Ryan,
Alan Menter,
Lyn Guenther,
Andrew Blauvelt,
Robert Bissonnette,
Fan Emily Yang,
Allison P Bleakman,
David A. Amato
Publication year - 2018
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.8
Subject(s) - ixekizumab , medicine , psoriasis , placebo , dermatology , double blinded , clinical trial , randomized controlled trial , psoriatic arthritis , secukinumab , alternative medicine , pathology
not Available. Disclosures: Study sponsored by Eli Lilly. Copyright 2018 SKIN
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom